Biogen Alzheimer’s data shows drug benefits; House plans to vote on Nancy Pelosi’s drug price bill; Ebola vaccine stockpile to increase to 500,000 doses.
Plus people moves at Ashfield, Area 23 and Envision Pharma Group.
Populus, a health media startup, will coordinate the airing of 15- to 60-second spots prior to and following telehealth consults.
While launches for two new sickle-cell treatments get underway, drugmakers find that their disease marketing work has just begun to scratch the surface.
That number got many of us at MM&M thinking: What else can be bought with $20,500,000,000,000?
Minnesota sues Juul over teen vaping; J&J says new tests found no asbestos in baby powder; Hospital groups challenge price transparency rule.
Several candidates relegated to the R&D graveyard re-emerged from their tombs this year and now headline the pharma developmental slate for 2020.
Medical & Health Consulting represents biopharma, health technology and medical device companies and professional medical associations.
It’s one thing to hear employees and management talk about how great a workplace’s culture is, but it’s another to view it in person. MM&M spent a day at Best Places to Work honoree Heartbeat to see what the fuss was about.
Dr. Stephen Hahn’s FDA nomination advances; Alphabet CEO to step down; Local governments opting out of federal opioid lawsuit.